Olanzapine for young PEople with aNorexia nervosa (OPEN): results of a feasibility study

Olanzapine for young PEople with aNorexia nervosa (OPEN): results of a feasibility study

Abstract Background Despite the availability of evidence-based treatments for anorexia nervosa (AN), remission rates are moderate, and mortality is high. Olanzapine is used as adjunct therapy for AN in case of insufficient response to first-line treatments, even though the evidence is limited. Its e...

Full description

Saved in:
Bibliographic Details
Main Authors: Olena Said, Dominic Stringer, Ece Sengun Filiz, Hiba Mutwalli, Sevgi Bektas, Melahat Nur Akkese, Vanessa Kellermann, Katie Ireland, Elizabeth Tyrrell-Bunge, Demelza Beishon-Murley, Joel W. T. Khor, Lee Allman, Joanna Barker, Nicus Kotze, Ben Carter, Mima Simic, Dilveer Singh Sually, Jessica Bentley, Allan H. Young, Sloane Madden, Sarah Byford, Sabine Landau, Vanessa Lawrence, Janet Treasure, Ulrike Schmidt, Dasha Nicholls, Hubertus Himmerich
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Psychiatry
Subjects:
Anorexia nervosa
Olanzapine
Feasibility
Recruitment
Adherence
Attrition
Online Access:https://doi.org/10.1186/s12888-024-06215-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12888-024-06215-y

Similar Items